Paper Details
- Home
- Paper Details
Corneal sterile infiltration induced by topical use of ocular hypotensive agent.
Author: ManabeYusuke, MochizukiKiyofumi, SawadaAkira
Original Abstract of the Article :
PURPOSE: To report two cases with corneal sterile infiltration presumably due to topical ocular hypotensive agent. METHOD: Case report. RESULTS: Case 1: A 65-year-old man presented with corneal opacity and neovascularization in his left eye. A diagnosis of glaucoma was made 2 years previously, and...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1177/1120672119850080
データ提供:米国国立医学図書館(NLM)
Corneal Sterile Infiltration Induced by Topical Ocular Hypotensive Agent
Ocular hypotensive agents are commonly used to treat glaucoma, but they can sometimes cause adverse effects. This study reports two cases of corneal sterile infiltration, a condition that can impair vision, potentially related to topical ocular hypotensive agent use. Researchers describe the cases of two patients who developed corneal sterile infiltration following the use of brimonidine eye drops. The study highlights the importance of monitoring for potential side effects of ocular hypotensive agents and emphasizes the need for careful patient selection and treatment optimization.
The Importance of Monitoring for Side Effects
This study underscores the importance of monitoring for potential side effects of ocular hypotensive agents. While these medications can be effective in treating glaucoma, they can also cause adverse effects, including corneal sterile infiltration. Healthcare providers should be vigilant in monitoring patients for any signs of adverse effects and should adjust treatment strategies as needed to minimize the risk of complications.
Navigating the Risks and Benefits of Ocular Hypotensive Agents
This study highlights the complex interplay of risks and benefits associated with ocular hypotensive agents. While these medications can effectively lower intraocular pressure and preserve vision, they can also cause adverse effects. Healthcare providers must carefully weigh the risks and benefits of these medications and make informed decisions about treatment based on individual patient needs.
Dr. Camel's Conclusion
This research, like a camel caravan navigating a desert landscape filled with potential hazards, reminds us of the importance of vigilant monitoring for side effects of ocular hypotensive agents. The study emphasizes the need for careful patient selection and treatment optimization to ensure the safe and effective use of these medications, while minimizing the risk of complications.
Date :
- Date Completed 2020-10-23
- Date Revised 2022-04-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.